{"id":4667,"date":"2025-10-03T13:54:52","date_gmt":"2025-10-03T10:54:52","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4667"},"modified":"2026-02-24T12:16:05","modified_gmt":"2026-02-24T09:16:05","slug":"could-axolotls-self-regenerative-ability-be-effective-in-treating-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/could-axolotls-self-regenerative-ability-be-effective-in-treating-duchenne-muscular-dystrophy\/","title":{"rendered":"Axolotl&#039;un Kendini Yenileme Yetene\u011fi Duchenne Musk\u00fcler Distrofi Tedavisinde Etkili Olabilir mi?"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Duchenne kas distrofisi (DMD), kas lifi b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fcn korunmas\u0131 i\u00e7in gerekli bir sitoskeletal protein olan distrofinin yoklu\u011fu veya i\u015flev bozuklu\u011fu ile karakterize ciddi bir X&#039;e ba\u011fl\u0131 genetik hastal\u0131kt\u0131r. Hastal\u0131k, tekrarlayan kas hasar\u0131na, yetersiz onar\u0131ma, ilerleyici fibroza, kas k\u00fctlesi ve fonksiyon kayb\u0131na ve sonunda kardiyopulmoner yetmezli\u011fe yol a\u00e7ar. Mevcut tedaviler (gen tedavisi, ekzon atlama, kortikosteroidler vb.) umut verici olmakla birlikte eksiktir. Temel zorluklardan biri, insanlarda kas rejenerasyonunun kas dejenerasyonuna ayak uyduramamas\u0131 ve skar olu\u015fumunun\/fibrozisin sonu\u00e7lar\u0131 k\u00f6t\u00fcle\u015ftirmesidir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Buna kar\u015f\u0131l\u0131k, baz\u0131 hayvanlar, \u00f6zellikle de aksolotl gibi semenderler, ola\u011fan\u00fcst\u00fc rejeneratif yetenekler sergiler. Uzuvlar\u0131n\u0131 yeniden b\u00fcy\u00fctebilir, i\u00e7 organlar\u0131n\u0131 onarabilir, omurili\u011fini yenileyebilir ve bunlar\u0131 b\u00fcy\u00fck \u00f6l\u00e7\u00fcde yara izi b\u0131rakmadan yapabilirler. Bu s\u00fcre\u00e7lerin h\u00fccresel, molek\u00fcler ve sistemik d\u00fczeylerde nas\u0131l i\u015fledi\u011fini anlamak, DMD i\u00e7in yeni tedavi yakla\u015f\u0131mlar\u0131 ortaya \u00e7\u0131karabilir.<\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#the-axolotl-why-its-special\">Axolotl: Neden \u00d6zeldir?<\/a><\/li><li><a href=\"#what-we-know-from-current-models-of-dmd-and-where-gaps-exist\">Mevcut DMD Modellerinden Bildiklerimiz ve Bo\u015fluklar\u0131n Nerede Oldu\u011fu<\/a><\/li><li><a href=\"#how-axolotl-research-might-help-dmd\">Axolotl Ara\u015ft\u0131rmas\u0131 DMD&#039;ye Nas\u0131l Yard\u0131mc\u0131 Olabilir?<\/a><\/li><li><a href=\"#possible-research-strategies-challenges-in-applying-axolotl-derived-insights-to-dmd\">Axolotl T\u00fcrevi Bilgilerin DMD&#039;ye Uygulanmas\u0131nda Olas\u0131 Ara\u015ft\u0131rma Stratejileri ve Zorluklar\u0131<\/a><\/li><li><a href=\"#specific-hypotheses-research-proposals-how-one-could-use-axolotl-insights-directly-in-dmd-research\">Belirli Hipotezler ve Ara\u015ft\u0131rma \u00d6nerileri: Axolotl \u0130\u00e7g\u00f6r\u00fcleri DMD Ara\u015ft\u0131rmalar\u0131nda Do\u011frudan Nas\u0131l Kullan\u0131labilir?<\/a><\/li><li><a href=\"#could-axolotls-be-used-as-a-model-of-dystrophin-deficiency\">Aksolotllar Distrofin Eksikli\u011finin Modeli Olarak Kullan\u0131labilir mi?<\/a><\/li><li><a href=\"#what-to-watch-for-key-metrics-if-you-were-designing-axolotl-inspired-dmd-therapies\">Axolotl&#039;dan \u0130lham Alan DMD Terapileri Tasarl\u0131yorsan\u0131z Nelere Dikkat Etmelisiniz \/ Temel \u00d6l\u00e7\u00fctler<\/a><\/li><li><a href=\"#challenges-limitations\">Zorluklar ve S\u0131n\u0131rlamalar<\/a><\/li><li><a href=\"#conclusion\">Sonu\u00e7<\/a><\/li><\/ul><\/nav><\/div>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"the-axolotl-why-its-special\">Axolotl: Neden \u00d6zeldir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Aksolotllar\u0131n baz\u0131 temel rejeneratif \u00f6zellikleri:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Uzuvlar\u0131n, dokular\u0131n, merkezi sinir sisteminin (MSS) ve i\u00e7 organlar\u0131n yara izi b\u0131rakmadan yenilenmesi.<a href=\"https:\/\/anatomypubs.onlinelibrary.wiley.com\/doi\/full\/10.1002\/dvdy.520\" target=\"_blank\" rel=\"noreferrer noopener\">Anatomi Yay\u0131nlar\u0131<\/a><\/li>\n\n\n\n<li>Kas liflerinin yeniden farkl\u0131la\u015fmas\u0131, sinir yenilenmesi, kan damarlar\u0131n\u0131n ve h\u00fccre d\u0131\u015f\u0131 matriksin yeniden in\u015fas\u0131 ve fonksiyonun geri kazan\u0131lmas\u0131 dahil olmak \u00fczere kas dokusunu yenileme yetene\u011fi. (Arka bacaklar da dahil olmak \u00fczere, uygun hizalama vb. ile uzuv kaslar\u0131n\u0131n yenilenmesine ili\u015fkin ayr\u0131nt\u0131l\u0131 \u00e7al\u0131\u015fmalar mevcuttur.) \u2013<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24325444\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Rejenerasyon s\u0131ras\u0131nda ve sonras\u0131nda g\u00fc\u00e7l\u00fc, d\u00fczenlenmi\u015f b\u00fcy\u00fcme sinyalleri, pozisyonel kimli\u011fin kontrol\u00fc (\u00f6rne\u011fin retinoik asit gradyanlar\u0131 yoluyla), protein sentezinin d\u00fczenlenmesi (\u00f6rne\u011fin mTOR yolu duyarl\u0131l\u0131\u011f\u0131), geli\u015fimsel ve k\u00f6k\/progenit\u00f6r h\u00fccre programlar\u0131n\u0131n aktivasyonu, ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131n\u0131n mod\u00fclasyonu vb. \u2013<a href=\"https:\/\/med.stanford.edu\/news\/insights\/2023\/07\/how-an-ultra-sensitive-on-off-switch-helps-axolotls-regrow-limbs.html\" target=\"_blank\" rel=\"noreferrer noopener\">Stanford T\u0131p Fak\u00fcltesi<\/a><\/li>\n\n\n\n<li>D\u00fc\u015f\u00fck kanser insidans\u0131 ve kanserojenlere kar\u015f\u0131 y\u00fcksek diren\u00e7. Aksolotlardan elde edilen baz\u0131 h\u00fccre \u00f6zlerinin belirli durumlarda t\u00fcm\u00f6r b\u00fcy\u00fcmesini tersine \u00e7evirdi\u011fi g\u00f6r\u00fclmektedir. Bu bulgular, rejeneratif proliferasyonun iyi kontrol edildi\u011fini g\u00f6stermektedir.<a href=\"https:\/\/anatomypubs.onlinelibrary.wiley.com\/doi\/full\/10.1002\/dvdy.520\" target=\"_blank\" rel=\"noreferrer noopener\">Anatomi Yay\u0131nlar\u0131<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Bu \u00f6zellikler, aksolotl&#039;u, rejenerasyonun baz\u0131 omurgal\u0131larda ba\u015far\u0131l\u0131 olurken di\u011ferlerinde (insanlar dahil) neden ba\u015far\u0131s\u0131z oldu\u011funu anlamak i\u00e7in g\u00fc\u00e7l\u00fc bir model haline getiriyor; \u00f6zellikle de kronik hasar\u0131n oldu\u011fu durumlarda.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-1024x576.jpg\" alt=\"Duchenne Musk\u00fcler Distrofi (DMD) Tedavisinde Axolotl Amfibisi\" class=\"wp-image-4683\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-1024x576.jpg 1024w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-300x169.jpg 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-768x432.jpg 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-1536x864.jpg 1536w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-18x10.jpg 18w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-747x420.jpg 747w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-150x84.jpg 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-696x392.jpg 696w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3-1068x601.jpg 1068w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-3.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-we-know-from-current-models-of-dmd-and-where-gaps-exist\">Mevcut DMD Modellerinden Bildiklerimiz ve Bo\u015fluklar\u0131n Nerede Oldu\u011fu<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Axolotl i\u00e7g\u00f6r\u00fclerini DMD&#039;ye ba\u011flamak i\u00e7in mevcut modellerin ne g\u00f6sterdi\u011fini anlamak yard\u0131mc\u0131 olur:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/dmdwarrior.com\/tr\/mdx-mice-in-research-of-duchenne-muscular-dystrophy\/\" target=\"_blank\" rel=\"noreferrer noopener\">MDX fare, klasik DMD modelidir.<\/a>: Fonksiyonel distrofin eksikli\u011fi, kas dejenerasyonu ve rejenerasyonu g\u00f6r\u00fclmesi, ancak hastal\u0131\u011f\u0131n seyrinin insanlardaki DMD&#039;ye g\u00f6re \u00e7ok daha hafif olmas\u0131: daha az fibrozis, daha etkili rejenerasyon, bir\u00e7ok vakada normale yak\u0131n ya\u015fam s\u00fcresi.<a href=\"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/1471-2164-6-98\" target=\"_blank\" rel=\"noreferrer noopener\">BioMed Central<\/a><\/li>\n\n\n\n<li>Daha b\u00fcy\u00fck hayvan modelleri (k\u00f6pekler, s\u0131\u00e7anlar) fibrozis, kardiyomiyopati vb. gibi insan hastal\u0131klar\u0131na daha \u00e7ok benzeyen daha \u015fiddetli fenotipler g\u00f6sterme e\u011filimindedir.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25740330\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/li>\n\n\n\n<li>Yap\u0131lan \u00e7al\u0131\u015fmalar sadece distrofin kayb\u0131n\u0131 de\u011fil, ayn\u0131 zamanda a\u015fa\u011f\u0131 ak\u0131\u015f i\u015flev bozuklu\u011funu da g\u00f6stermi\u015ftir: uydu h\u00fccrelerinin t\u00fckenmesi veya bozulmas\u0131, miyoblastlarda (\u00f6rne\u011fin MyoD, Myog, vb.) gen ifadesinin de\u011fi\u015fmesi, artan inflamasyon, bozuk enerji metabolizmas\u0131.<a href=\"https:\/\/ouci.dntb.gov.ua\/en\/works\/4aXRAb07\" target=\"_blank\" rel=\"noreferrer noopener\">OUCI<\/a><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bo\u015fluklar ve zorluklar<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u0130nsan DMD&#039;sinde rejeneratif kapasite s\u0131n\u0131rl\u0131d\u0131r ve zamanla dejenerasyona ayak uyduramaz; kas dokusunun yerini fibrozis al\u0131r.<\/li>\n\n\n\n<li>Yara izi olu\u015fumu ve yanl\u0131\u015f d\u00fczenlenmi\u015f ba\u011f\u0131\u015f\u0131kl\u0131k tepkileri en b\u00fcy\u00fck engellerdir.<\/li>\n\n\n\n<li>Bir\u00e7ok hayvan modeli insan hastal\u0131klar\u0131n\u0131n t\u00fcm y\u00f6nlerini (\u00f6rne\u011fin kalp tutulumu, solunum azalmas\u0131, uzun vadeli sonu\u00e7lar) yans\u0131tmaz.<\/li>\n\n\n\n<li>Hayvan modellerinden elde edilen bulgular\u0131n insanlara aktar\u0131lmas\u0131 yava\u015f olmu\u015ftur; gen b\u00fcy\u00fckl\u00fc\u011f\u00fc, imm\u00fcnojenite, iletim vb. engellerdir.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"how-axolotl-research-might-help-dmd\">Axolotl Ara\u015ft\u0131rmas\u0131 DMD&#039;ye Nas\u0131l Yard\u0131mc\u0131 Olabilir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Aksolotl \u00e7al\u0131\u015fmalar\u0131n\u0131n DMD i\u00e7in yeni klinik ara\u015ft\u0131rmalara, tedavilere veya anlay\u0131\u015fa nas\u0131l katk\u0131da bulunabilece\u011fi a\u015fa\u011f\u0131da belirtilmi\u015ftir:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u0130\u00e7g\u00f6r\u00fc alan\u0131<\/th><th>Aksolotl ara\u015ft\u0131rmalar\u0131 nas\u0131l uygulan\u0131r?<\/th><th>DMD i\u00e7in potansiyel \u00e7evirisel fayda<\/th><\/tr><\/thead><tbody><tr><td><strong>Fibrozis olmadan kas rejenerasyonu \/ izsiz onar\u0131m<\/strong><\/td><td>Axolotllar uzuvlardaki kas dokusunu d\u00fc\u015f\u00fck yara iziyle yeniler; yara epiteli h\u0131zla olu\u015fur, blastema olu\u015fumu olur, kontroll\u00fc inflamasyon, hassas yeniden \u015fekillenme olur.<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-169X.2010.01208.x\" target=\"_blank\" rel=\"noreferrer noopener\">Wiley \u00c7evrimi\u00e7i K\u00fct\u00fcphanesi<\/a><\/td><td>Fibrozu bask\u0131layan ve rejeneratif yara izi b\u0131rakmayan iyile\u015fmeyi destekleyen sinyallerin anla\u015f\u0131lmas\u0131, DMD&#039;de fibrozu azaltmaya y\u00f6nelik tedavilere (\u00f6rne\u011fin ECM yeniden \u015fekillenmesini, fibroblast aktivasyonunu, ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclasyonunu hedefleme) rehberlik edebilir.<\/td><\/tr><tr><td><strong>Pozisyonel kimlik ve kontroll\u00fc yeniden b\u00fcy\u00fcme<\/strong><\/td><td>Son \u00e7al\u0131\u015fmalar, retinoik asit gradyanlar\u0131n\u0131n ve onu par\u00e7alayan enzimlerin (CYP26B1), aksolotl uzuvlar\u0131nda rejenerasyon ge\u00e7iren h\u00fccrelere nerede olduklar\u0131n\u0131 (proksimal mi yoksa distal mi) s\u00f6ylemede kritik \u00f6neme sahip oldu\u011funu g\u00f6stermektedir. Shox gibi genler bu konumsal kimlikte rol oynar.<a href=\"https:\/\/www.nsf.gov\/news\/new-axolotl-study-gives-researchers-leg-work-towards-limb\" target=\"_blank\" rel=\"noreferrer noopener\">NSF \u2013 Ulusal Bilim Vakf\u0131<\/a><\/td><td>DMD i\u00e7in, uzuv \u00f6r\u00fcnt\u00fclemesi ba\u015fl\u0131 ba\u015f\u0131na daha az do\u011frudan alakal\u0131 olsa da, pozisyonel haf\u0131zay\u0131 anlamak, yenilenen liflerin hizalanmas\u0131na, mimarinin do\u011fru \u015fekilde yeniden yap\u0131land\u0131r\u0131lmas\u0131na, k\u00f6k\/progenitor h\u00fccre tedavilerinin do\u011fru kas geometrisini geri kazand\u0131rmas\u0131na yard\u0131mc\u0131 olabilir.<\/td><\/tr><tr><td><strong>Geli\u015fimsel ve k\u00f6k\/progenitor programlar\u0131n\u0131n aktivasyonu<\/strong><\/td><td>Yaralanma sonras\u0131 aksolotlarda pluripotens, h\u00fccre d\u00f6ng\u00fcs\u00fc, sitoskeletal yeniden d\u00fczenleme vb. ile ili\u015fkili genlerin erken d\u00f6nemde yukar\u0131 reg\u00fclasyonu. Ayr\u0131ca ultra hassas mTOR anahtar\u0131 (aksolot mTOR), yaralanmaya yan\u0131t olarak protein sentezinin daha esnek bir \u015fekilde aktive edilmesini sa\u011flar.<a href=\"https:\/\/med.stanford.edu\/news\/insights\/2023\/07\/how-an-ultra-sensitive-on-off-switch-helps-axolotls-regrow-limbs.html\" target=\"_blank\" rel=\"noreferrer noopener\">Stanford T\u0131p Fak\u00fcltesi<\/a><\/td><td>\u0130nsan kaslar\u0131nda rejeneratif kapasiteyi art\u0131rmaya y\u00f6nelik hedefler \u00f6nerilebilir (\u00f6rne\u011fin, uydu h\u00fccre aktivitesini art\u0131rma, protein sentezini kontrol etme, metabolik programlama). Belki de kronik hasar veya ya\u015flanma nedeniyle DMD&#039;de sessizle\u015fen geli\u015fimsel yollar\u0131 &quot;yeniden canland\u0131rmak&quot; i\u00e7in tedaviler.<\/td><\/tr><tr><td><strong>Ba\u011f\u0131\u015f\u0131kl\u0131k tepkisi ve iltihaplanma<\/strong><\/td><td>Aksolotllar, kronik hasar yerine rejenerasyonu destekleyen bir ba\u011f\u0131\u015f\u0131kl\u0131k tepkisiyle yara iyile\u015fmesini y\u00f6netir. Omurilik yaralanmas\u0131ndan sonra aksolotllar ve rejeneratif olmayan t\u00fcrler aras\u0131ndaki transkripsiyonel kar\u015f\u0131la\u015ft\u0131rmalar, ba\u011f\u0131\u015f\u0131kl\u0131k yolu etkile\u015fimindeki farkl\u0131l\u0131klar\u0131 vurgulamaktad\u0131r.<a href=\"https:\/\/www.mdpi.com\/2073-4425\/14\/12\/2189\" target=\"_blank\" rel=\"noreferrer noopener\">MDPI<\/a><\/td><td>DMD&#039;de kronik inflamasyon, hasara ve fibroza katk\u0131da bulunur. Aksolotlarda rejenerasyonla uyumlu inflamasyonun nas\u0131l \u00e7\u00f6z\u00fcld\u00fc\u011f\u00fcn\u00fc anlamak, kas onar\u0131m\u0131n\u0131 engellemek yerine ona yard\u0131mc\u0131 olan anti-inflamatuar veya imm\u00fcnomod\u00fclat\u00f6r tedavilere rehberlik edebilir.<\/td><\/tr><tr><td><strong>Rejenerasyonun molek\u00fcler d\u00fczenleyicileri<\/strong><\/td><td>\u00c7al\u0131\u015fmalar, omurgal\u0131larda korunan ve aksolotl rejenerasyonu s\u0131ras\u0131nda daha y\u00fcksek oranda ifade edilen aday genleri (\u00f6rne\u011fin FSTL1, ADAMTS17, GPX7, CTHRC1) belirlemi\u015ftir. Ayr\u0131ca mTOR duyarl\u0131l\u0131\u011f\u0131 ve retinoik asit gradyanlar\u0131 gibi mekanizmalar da mevcuttur.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39575453\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/td><td>Bu korunan d\u00fczenleyiciler ila\u00e7 hedefleri haline gelebilir: \u0130fadeleri veya aktiviteleri insan kaslar\u0131nda (veya uydu h\u00fccrelerinde) rejenerasyonu art\u0131rmak i\u00e7in mod\u00fcle edilebilirse, DMD&#039;de hastal\u0131k ilerlemesi yava\u015flat\u0131labilir. \u00d6rne\u011fin, FSTL1 vb.&#039;yi taklit eden veya art\u0131ran molek\u00fcller.<\/td><\/tr><tr><td><strong>Doku iskelesi ve ECM dinamikleri<\/strong><\/td><td>Aksolotl uzuv rejenerasyonu, blastema olu\u015fumuna ve yeniden b\u00fcy\u00fcmesine olanak sa\u011flayan koordineli ECM y\u0131k\u0131m\u0131 ve rekonstr\u00fcksiyonunu (\u00f6rne\u011fin metaloproteinazlar, fibroblastlar vb.) i\u00e7erir. Aksolotl&#039;daki uzun kemikler \u00fczerinde yap\u0131lan \u00e7al\u0131\u015fmalarda, b\u00fcy\u00fck defektlerde rejenerasyonu desteklemek i\u00e7in iskeleler ve b\u00fcy\u00fcme fakt\u00f6rleri de kullan\u0131lm\u0131\u015ft\u0131r.<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4476796\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ulusal T\u0131p K\u00fct\u00fcphanesi<\/a><\/td><td>DMD&#039;de kas yap\u0131s\u0131 bozulur; fibrozis ve ECM sertle\u015fmesi sorunlard\u0131r. ECM yeniden \u015fekillenmesine ve aksolotl modellerinden elde edilen iskele tasar\u0131m\u0131na ili\u015fkin bilgiler, distrofik kaslarda rejenerasyonu desteklemek i\u00e7in biyomalzemelere veya h\u00fccre iletim iskelelerine bilgi sa\u011flayabilir.<\/td><\/tr><tr><td><strong>Transgenez ve gen d\u00fczenleyici i\u00e7g\u00f6r\u00fcler<\/strong><\/td><td>Axolotl transgenik y\u00f6ntemleri geli\u015fti; ara\u015ft\u0131rmac\u0131lar rejenerasyon \u00fczerindeki etkileri g\u00f6rmek i\u00e7in genleri manip\u00fcle edebiliyorlar (knock-out&#039;lar, haberci hatlar).<a href=\"https:\/\/anatomypubs.onlinelibrary.wiley.com\/doi\/full\/10.1002\/dvdy.357\" target=\"_blank\" rel=\"noreferrer noopener\">Anatomi Yay\u0131nlar\u0131<\/a><\/td><td>Aksolotl \u00e7al\u0131\u015fmalar\u0131ndan gen d\u00fczenleyici a\u011flar\u0131n \u00e7evrilmesi, insan homologlar\u0131n\u0131n veya m\u00fcdahale yollar\u0131n\u0131n belirlenmesine yard\u0131mc\u0131 olabilir; ayr\u0131ca gen terapisi hedeflerinin do\u011frulanmas\u0131na da yard\u0131mc\u0131 olabilir (\u00f6rne\u011fin, rejenerasyona yard\u0131mc\u0131 olan veya hasar\u0131 iyile\u015ftiren distrofin olmayan genler).<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"possible-research-strategies-challenges-in-applying-axolotl-derived-insights-to-dmd\">Axolotl T\u00fcrevi Bilgilerin DMD&#039;ye Uygulanmas\u0131nda Olas\u0131 Ara\u015ft\u0131rma Stratejileri ve Zorluklar\u0131<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Potansiyel y\u00fcksek olmakla birlikte \u00e7eviri i\u00e7in dikkat edilmesi gereken \u00f6nemli hususlar ve ad\u0131mlar bulunmaktad\u0131r:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Homoloji ve koruma<\/strong>\n<ul class=\"wp-block-list\">\n<li>Aksolotllarda tan\u0131mlanan herhangi bir gen\/yol i\u00e7in, insanlarda (veya memelilerde) i\u015flevsel bir kar\u015f\u0131l\u0131\u011f\u0131n\u0131n olup olmad\u0131\u011f\u0131 ve d\u00fczenleyici ba\u011flam\u0131n benzer olup olmad\u0131\u011f\u0131 kontrol edilmelidir.<\/li>\n\n\n\n<li>Baz\u0131 genler olduk\u00e7a korunmu\u015ftur; di\u011ferleri ise d\u00fczenleme, dozaj ve etkile\u015fim partnerleri a\u00e7\u0131s\u0131ndan farkl\u0131l\u0131k g\u00f6sterebilir. Aksolotl transkriptomikleri (blastema ve ya\u015fl\u0131 uzuvlar) gibi \u00e7al\u0131\u015fmalar, korunan gen setlerini ortaya \u00e7\u0131karmaya ba\u015flam\u0131\u015ft\u0131r.<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39575453\/\" target=\"_blank\" rel=\"noreferrer noopener\">PubMed<\/a><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Kronik hasar\u0131n modellenmesi<\/strong>\n<ul class=\"wp-block-list\">\n<li>DMD, devam eden dejenerasyon\/rejenerasyon, kronik inflamasyon, oksidatif stres vb. d\u00f6ng\u00fclerini i\u00e7erir. Aksolotl&#039;un akut hasar\/rejenerasyon modeli farkl\u0131l\u0131k g\u00f6sterebilir. Bu bo\u015flu\u011fu kapatmak i\u00e7in, rejeneratif yollar\u0131n zaman i\u00e7inde aktif tutulup tutulamayaca\u011f\u0131n\u0131 g\u00f6rmek \u00fczere tekrarlayan hasar veya s\u00fcrekli stres i\u00e7eren modeller gerekir.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>\u00d6l\u00e7ekleme, g\u00fc\u00e7 ve i\u015flevsel sonu\u00e7lar<\/strong>\n<ul class=\"wp-block-list\">\n<li>Dokuyu yenilemek bir \u015feydir; g\u00fcc\u00fc, kuvvet \u00e7\u0131kt\u0131s\u0131n\u0131, n\u00f6rom\u00fcsk\u00fcler kav\u015fak stabilitesini, do\u011fru lif tipini, damar beslemesini vb. geri kazand\u0131rmak ba\u015fka bir \u015feydir. Translasyonel \u00e7al\u0131\u015fma sadece histolojiyi de\u011fil, ayn\u0131 zamanda memeli (veya muhtemelen insan) dokular\u0131nda veya organlar\u0131nda i\u015flevsel \u00f6l\u00e7\u00fcmleri de test etmelidir.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>\u0130mm\u00fcnoloji ve fibrozis<\/strong>\n<ul class=\"wp-block-list\">\n<li>\u0130nsanlar (ve memeli modeller) yaralanma sonras\u0131 fibroz geli\u015ftirme e\u011filimindedir; aksolotlarda ise bu g\u00f6r\u00fclmez (veya \u00e7ok daha az oranda). Aksolotlarda fibrotik yara izini neyin \u00f6nledi\u011fini (ba\u011f\u0131\u015f\u0131kl\u0131k bask\u0131lanmas\u0131\/d\u00fczenlenmesi, fibroblast davran\u0131\u015f\u0131, ECM yeniden \u015fekillenmesi) belirlemek \u00e7ok \u00f6nemlidir; ancak insan ba\u011f\u0131\u015f\u0131kl\u0131k sistemi daha karma\u015f\u0131kt\u0131r ve daha kronik aktivasyona sahiptir, vb.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Teslimat ve g\u00fcvenlik<\/strong>\n<ul class=\"wp-block-list\">\n<li>Aksolotl benzeri rejeneratif yollar\u0131 aktive eden molek\u00fcller (k\u00fc\u00e7\u00fck molek\u00fcller, proteinler, gen terapisi vekt\u00f6rleri) bulsan\u0131z bile, bunlar\u0131 DMD hastalar\u0131nda (\u00f6zellikle geni\u015f v\u00fccut b\u00f6lgelerinde) insan kas\u0131na (veya di\u011fer gerekli dokulara) g\u00fcvenli ve etkili bir \u015fekilde iletmek hi\u00e7 de kolay de\u011fildir. Ayr\u0131ca, uzun vadeli g\u00fcvenlik de \u00f6nemlidir: rejenerasyon genellikle h\u00fccre \u00e7o\u011falmas\u0131 (t\u00fcm\u00f6r riski), yanl\u0131\u015f desenlenme vb. i\u00e7erir.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Etik ve pratik s\u0131n\u0131rlamalar<\/strong>\n<ul class=\"wp-block-list\">\n<li>Aksolotl bir amfibidir; omurgal\u0131 olmas\u0131na ra\u011fmen evrimsel olarak uzakt\u0131r. V\u00fccut \u0131s\u0131s\u0131, metabolizma, \u00f6l\u00e7ek, ya\u015fam s\u00fcresi vb. a\u00e7\u0131lardan farkl\u0131l\u0131klar g\u00f6sterir. Bulgular\u0131 yorumlamak her zaman t\u00fcr farkl\u0131l\u0131klar\u0131yla ilgilenmeyi gerektirecektir.<\/li>\n\n\n\n<li>Aksolotl soylar\u0131n\u0131n, transgenez tekniklerinin ve altyap\u0131n\u0131n eri\u015filebilirli\u011fi, bunlar\u0131n ne kadar yayg\u0131n olarak kullan\u0131ld\u0131\u011f\u0131n\u0131 s\u0131n\u0131rlayabilir (ancak \u00e7al\u0131\u015fmalar artmaktad\u0131r).<a href=\"https:\/\/anatomypubs.onlinelibrary.wiley.com\/doi\/full\/10.1002\/dvdy.357\" target=\"_blank\" rel=\"noreferrer noopener\">Anatomi Yay\u0131nlar\u0131<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-1024x576.jpg\" alt=\"Duchenne Musk\u00fcler Distrofi (DMD) Tedavisinde Axolotl Amfibisi\" class=\"wp-image-4682\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-1024x576.jpg 1024w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-300x169.jpg 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-768x432.jpg 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-1536x864.jpg 1536w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-18x10.jpg 18w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-747x420.jpg 747w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-150x84.jpg 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-696x392.jpg 696w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2-1068x601.jpg 1068w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-2.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"specific-hypotheses-research-proposals-how-one-could-use-axolotl-insights-directly-in-dmd-research\">Belirli Hipotezler ve Ara\u015ft\u0131rma \u00d6nerileri: Axolotl \u0130\u00e7g\u00f6r\u00fcleri DMD Ara\u015ft\u0131rmalar\u0131nda Do\u011frudan Nas\u0131l Kullan\u0131labilir?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u0130\u015fte DMD&#039;ye yard\u0131mc\u0131 olmak i\u00e7in aksolotl bulgular\u0131n\u0131 kullanabilecek baz\u0131 somut ara\u015ft\u0131rma fikirleri (hipotezler + deneyler):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hipotez<\/strong>:Aksolot blastema olu\u015fumu s\u0131ras\u0131nda korunan genlerden bir veya daha fazlas\u0131 yukar\u0131 d\u00fczenlenir (\u00f6rn. <em>FSTL1, ADAMTS17, GPX7, CTHRC1<\/em>) distrofik ko\u015fullar alt\u0131nda memeli uydu h\u00fccresi fonksiyonunu art\u0131r\u0131r.<br><strong>Deneysel plan<\/strong>: H\u00fccre k\u00fclt\u00fcr\u00fc kullanarak, bu genlerin insan homologlar\u0131n\u0131n a\u015f\u0131r\u0131 ekspresyonunu (veya rekombinant protein tedavisini) distrofik miyoblastlarda (mdx farelerinden veya insan DMD hastalar\u0131ndan) test edin ve \u00e7o\u011falman\u0131n, farkl\u0131la\u015fman\u0131n, hayatta kalman\u0131n ve hasara kar\u015f\u0131 direncin iyile\u015fip iyile\u015fmedi\u011fini g\u00f6r\u00fcn.<\/li>\n\n\n\n<li><strong>Hipotez<\/strong>: Retinoik asit sinyallemesinin (veya CYP26B1) mod\u00fclasyonu kas rejenerasyonunu etkileyebilir ve distrofik kaslardaki fibrotik d\u00fczensizli\u011fi azaltabilir.<br><strong>Deneysel plan<\/strong>: Mdx fare veya s\u0131\u00e7an modellerinde retinoik asit sentezi veya bozunmas\u0131n\u0131n k\u00fc\u00e7\u00fck molek\u00fcll\u00fc mod\u00fclat\u00f6rlerini kullan\u0131n, sadece kas rejenerasyonunu de\u011fil ayn\u0131 zamanda mimarisini, fibrozisini, NMJ b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc ve fonksiyonel g\u00fcc\u00fcn\u00fc inceleyin.<\/li>\n\n\n\n<li><strong>Hipotez<\/strong>: mTOR duyarl\u0131l\u0131\u011f\u0131 (\u00f6rne\u011fin aksolotl&#039;un ultra hassas mTOR&#039;u), yaralanmadan sonra g\u00fc\u00e7l\u00fc protein sentezine olanak sa\u011flayan \u015feyin bir par\u00e7as\u0131d\u0131r; mTOR yolunun kontroll\u00fc bir \u015fekilde art\u0131r\u0131lmas\u0131 distrofik kaslara yard\u0131mc\u0131 olabilir.<br><strong>Deneysel plan<\/strong>: Distrofik ve normal kaslardaki mTOR yola\u011f\u0131n\u0131n aktivitesini yaralanmadan sonra kar\u015f\u0131la\u015ft\u0131r\u0131n; mTOR aktivat\u00f6rlerini veya mod\u00fclat\u00f6rlerini k\u00fc\u00e7\u00fck veya b\u00fcy\u00fck hayvan modellerinde test edin, yan etkileri (\u00f6rne\u011fin uyumsuz hipertrofi veya metabolik stres) dikkatlice izleyin.<\/li>\n\n\n\n<li><strong>Hipotez<\/strong>:Aksolotlun tepkisini taklit eden ba\u011f\u0131\u015f\u0131kl\u0131k mod\u00fclasyonu DMD&#039;de daha iyi rejenerasyonu destekleyebilir.<br><strong>Deneysel plan<\/strong>: Aksolotl rejenerasyonunda ve DMD&#039;de ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresi infiltrasyonunu ve sitokin profillerini inceleyin; inflamasyonun \u00e7\u00f6z\u00fclmesiyle ili\u015fkili molek\u00fclleri belirleyin (\u00f6rne\u011fin, spesifik interl\u00f6kinler, b\u00fcy\u00fcme fakt\u00f6rleri). Ard\u0131ndan, hayvan DMD modellerinde bu molek\u00fcllerin blokerlerini veya g\u00fc\u00e7lendiricilerini test edin.<\/li>\n\n\n\n<li><strong>Hibrit veya &#039;yenileme iskelesi&#039; malzemelerinin kullan\u0131m\u0131<\/strong>: DMD&#039;de kas onar\u0131m\u0131 i\u00e7in implant veya iskele tasarlamak amac\u0131yla aksolotl ECM\/rejeneratif iskele \u00e7al\u0131\u015fmalar\u0131 (\u00f6rne\u011fin iskeleler + b\u00fcy\u00fcme fakt\u00f6rleri kullan\u0131larak kemik defekti onar\u0131m\u0131) temel al\u0131nm\u0131\u015ft\u0131r (\u00f6rne\u011fin par\u00e7alanan ve uydu h\u00fccre g\u00f6\u00e7\u00fcne izin veren dolgu iskeleleri).<\/li>\n\n\n\n<li><strong>Genetik\/transgenik ara\u00e7lar<\/strong>: Transgenik aksolot hatlar\u0131n\u0131 distrofin homologlar\u0131n\u0131 ifade edecek \u015fekilde geli\u015ftirmek (e\u011fer mevcutsa) veya aksolotlardaki distrofin eksikli\u011fini modellemek (e\u011fer m\u00fcmk\u00fcnse) \u2192 zor olsa da, distrofin eksik oldu\u011funda belirli geli\u015fimsel programlar\u0131n nas\u0131l bask\u0131land\u0131\u011f\u0131n\u0131 veya de\u011fi\u015fti\u011fini anlamaya yard\u0131mc\u0131 olabilir.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"could-axolotls-be-used-as-a-model-of-dystrophin-deficiency\">Aksolotllar Distrofin Eksikli\u011finin Modeli Olarak Kullan\u0131labilir mi?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Bir soru \u015fu: Distrofin eksikli\u011fi olan (veya distrofin benzeri bir proteinin devre d\u0131\u015f\u0131 b\u0131rak\u0131ld\u0131\u011f\u0131\/devre d\u0131\u015f\u0131 b\u0131rak\u0131ld\u0131\u011f\u0131) aksolotlar\u0131 do\u011frudan DMD modellemek i\u00e7in kullanan herhangi bir ara\u015ft\u0131rma var m\u0131?<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Literat\u00fcrde, aksolotlar\u0131n distrofin ortologu olmadan genetik olarak modifiye edildi\u011fini veya do\u011frudan bir DMD modeli olarak kullan\u0131ld\u0131\u011f\u0131n\u0131 g\u00f6steren g\u00fcncel, yay\u0131nlanm\u0131\u015f bir \u00e7al\u0131\u015fma bulamad\u0131k. Standart DMD modelleri memeliler (mdx fareleri, DMD s\u0131\u00e7anlar\u0131, k\u00f6pek modelleri) olmaya devam ediyor.<\/li>\n\n\n\n<li>Ancak yap\u0131lan \u00e7al\u0131\u015fmalar, aksolotlarda rejeneratif biyoloji ve hastal\u0131klarda (\u00f6rne\u011fin n\u00f6rodejenerasyonda) rol oynayan insan proteinlerinin bir\u00e7ok homologunu tespit etmi\u015ftir. Bu, &quot;ara\u00e7 seti&quot; genlerinin \u00e7o\u011funun mevcut oldu\u011funu g\u00f6stermektedir.<a href=\"https:\/\/www.mdpi.com\/2073-4425\/15\/3\/310\" target=\"_blank\" rel=\"noreferrer noopener\">MDPI<\/a><\/li>\n\n\n\n<li>Aksolotllardaki transgenik ara\u00e7lar geli\u015fiyor, dolay\u0131s\u0131yla bilim insanlar\u0131 distrofin (veya distrofin benzeri bir gen) i\u00e7in mutasyonlar veya bask\u0131lamalar uygulayabilirse, o zaman distrofin yoklu\u011funda rejeneratif mekanizmalar\u0131n nas\u0131l davrand\u0131\u011f\u0131 ve aksolotllar\u0131n rejenerasyonunun baz\u0131 eksiklikleri telafi edip edemeyece\u011fi veya bunlar\u0131 atlat\u0131p atlatamayaca\u011f\u0131 g\u00f6zlemlenebilir.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Dolay\u0131s\u0131yla, do\u011frudan aksolotl DMD modelleri hen\u00fcz olu\u015fturulmam\u0131\u015f olsa da (ara\u015ft\u0131rd\u0131\u011f\u0131m\u0131z literat\u00fcre g\u00f6re), bu t\u00fcr modellerin geli\u015ftirilme potansiyeli bulunmaktad\u0131r.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-1024x576.jpg\" alt=\"Duchenne Musk\u00fcler Distrofi (DMD) Tedavisinde Axolotl Amfibisi\" class=\"wp-image-4681\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-1024x576.jpg 1024w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-300x169.jpg 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-768x432.jpg 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-1536x864.jpg 1536w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-18x10.jpg 18w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-747x420.jpg 747w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-150x84.jpg 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-696x392.jpg 696w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1-1068x601.jpg 1068w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/09\/Axolotl-1.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"what-to-watch-for-key-metrics-if-you-were-designing-axolotl-inspired-dmd-therapies\">Axolotl&#039;dan \u0130lham Alan DMD Terapileri Tasarl\u0131yorsan\u0131z Nelere Dikkat Etmelisiniz \/ Temel \u00d6l\u00e7\u00fctler<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c7evirisel uygunlu\u011fun sa\u011flanmas\u0131 i\u00e7in ara\u015ft\u0131rman\u0131n \u015funlar\u0131 de\u011ferlendirmesi gerekir:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Kas histolojisi<\/strong>: lif boyutu, merkezi \u00e7ekirdekler, nekroz\/rejenerasyon d\u00f6ng\u00fcleri, fibrozis, ya\u011f infiltrasyonu.<\/li>\n\n\n\n<li><strong>Fonksiyonel g\u00fc\u00e7<\/strong>: kuvvet olu\u015fturma, dayan\u0131kl\u0131l\u0131k, kas\u0131lma \u00f6zellikleri.<\/li>\n\n\n\n<li><strong>N\u00f6rom\u00fcsk\u00fcler kav\u015fak (NMJ) b\u00fct\u00fcnl\u00fc\u011f\u00fc<\/strong>: DMD ayn\u0131 zamanda NMJ&#039;leri de dejenerasyon\/rejenerasyon d\u00f6ng\u00fcleri yoluyla etkiledi\u011finden.<\/li>\n\n\n\n<li><strong>\u0130ltihaplanma \/ ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccresi infiltrasyonu<\/strong> ve zaman i\u00e7inde \u00e7\u00f6z\u00fcn\u00fcrl\u00fck: hem akut hem de kronik belirte\u00e7ler.<\/li>\n\n\n\n<li><strong>Ekstrasel\u00fcler matris (ECM) de\u011fi\u015fiklikleri<\/strong>: kollajen birikimi, sertlik, iskele \u00f6zellikleri.<\/li>\n\n\n\n<li><strong>Molek\u00fcler imzalar<\/strong>: Geli\u015fimsel\/rejeneratif genlerin ifadesi, protein sentez kapasitesi (mTOR vb.), metabolik durum (mitokondri, reaktif oksijen stresi).<\/li>\n\n\n\n<li><strong>Yan etkiler<\/strong>: yanl\u0131\u015f desen olu\u015fturma, t\u00fcm\u00f6r olu\u015fumu, hedef d\u0131\u015f\u0131 etkiler, ba\u011f\u0131\u015f\u0131kl\u0131k tepkileri riski.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"challenges-limitations\">Zorluklar ve S\u0131n\u0131rlamalar<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>T\u00fcr farkl\u0131l\u0131klar\u0131<\/strong>: Yenilenme ortam\u0131 (s\u0131cakl\u0131k, metabolizma, ya\u015fam s\u00fcresi, ba\u011f\u0131\u015f\u0131kl\u0131k sistemi) amfibi ve memelilerde farkl\u0131d\u0131r. Baz\u0131 mekanizmalar uyumsuz olabilir veya farkl\u0131 \u015fekilde \u00e7al\u0131\u015fabilir.<\/li>\n\n\n\n<li><strong>Kronik ve akut yaralanma<\/strong>: Aksolotl \u00e7al\u0131\u015fmalar\u0131 genellikle DMD&#039;de g\u00f6r\u00fclen kronik, biriken hasar\u0131 de\u011fil, akut hasar\/yenilenmeyi inceler. Rejeneratif programlar kronik ortamlarda &quot;t\u00fckenirse&quot; veya engellenirse, aksolotllardan elde edilen bulgular etkisini kaybedebilir.<\/li>\n\n\n\n<li><strong>\u0130nsanlarda teslimat<\/strong>: Hedef, k\u00fc\u00e7\u00fck molek\u00fcller, b\u00fcy\u00fcme fakt\u00f6rleri, gen terapisi, h\u00fccre terapisi vb. yoluyla rejenerasyonu art\u0131rmaksa, bunlar\u0131 insanlardaki b\u00fcy\u00fck kas k\u00fctlelerine g\u00fcvenli ve etkili bir \u015fekilde ula\u015ft\u0131rmak zordur. DMD sistemiktir; bir\u00e7ok kas\u0131 etkiler.<\/li>\n\n\n\n<li><strong>Zamanlama<\/strong>: DMD&#039;de m\u00fcdahalelerin erken (masif fibroz ve uydu h\u00fccre kayb\u0131ndan \u00f6nce) yap\u0131lmas\u0131 gerekebilir. Aksolotl olaylar\u0131n\u0131n \u00e7o\u011fu yaralanmadan hemen sonra meydana gelir; DMD hastalar\u0131nda ise hasar ve fibroz genellikle tan\u0131 ve tedaviden \u00e7ok \u00f6nce ortaya \u00e7\u0131kar.<\/li>\n\n\n\n<li><strong>D\u00fczenleme ve g\u00fcvenlik<\/strong>:H\u00fccre \u00e7o\u011falmas\u0131n\u0131 (rejenerasyonu taklit etmek i\u00e7in) te\u015fvik eden herhangi bir tedavi, s\u0131k\u0131 bir \u015fekilde kontrol edilmedi\u011fi takdirde kanser veya istenmeyen doku b\u00fcy\u00fcmesi riskini de art\u0131r\u0131r.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"conclusion\">Sonu\u00e7<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Aksolotl, yara izi b\u0131rakmayan onar\u0131m, b\u00fcy\u00fcme ve pozisyonel kimli\u011fin hassas kontrol\u00fc, geli\u015fimsel yollar\u0131n etkili aktivasyonu, ba\u011f\u0131\u015f\u0131kl\u0131k tepkisinin g\u00fc\u00e7l\u00fc mod\u00fclasyonu ve y\u00fcksek d\u00fczeyde d\u00fczenlenmi\u015f ECM yeniden \u015fekillenmesini i\u00e7eren dikkate de\u011fer bir rejeneratif ara\u00e7 setine sahiptir. Aksolotllarda DMD&#039;nin do\u011frudan modelleri hen\u00fcz olu\u015fturulmam\u0131\u015f olsa da, ilgili genlerin ve yollar\u0131n \u00e7o\u011funun korunmu\u015f yap\u0131s\u0131, aksolotl ara\u015ft\u0131rmalar\u0131ndan elde edilen bilgilerin DMD&#039;deki tedavilere veya mekanistik anlay\u0131\u015fa katk\u0131da bulunma konusunda ger\u00e7ek bir potansiyel ta\u015f\u0131d\u0131\u011f\u0131 anlam\u0131na gelir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Potansiyel \u00e7\u0131kar\u0131mlar \u015funlar\u0131 i\u00e7erir:<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Rejenerasyonu art\u0131rmak veya fibrozu yava\u015flatmak i\u00e7in yeni molek\u00fcler hedeflerin (genler, sinyal yollar\u0131) tan\u0131mlanmas\u0131.<\/li>\n\n\n\n<li>Aksolotl rejeneratif sinyallerini taklit eden k\u00fc\u00e7\u00fck molek\u00fcl veya biyolojiklerin geli\u015ftirilmesi (\u00f6rne\u011fin retinoik asit d\u00fczenlemesi, mTOR mod\u00fclasyonu).<\/li>\n\n\n\n<li>Aksolotl ECM dinamiklerinden yararlan\u0131larak iskele veya biyomalzeme tasar\u0131m\u0131.<\/li>\n\n\n\n<li>Ba\u011f\u0131\u015f\u0131kl\u0131k tepkisinin rejenerasyonu engellemek yerine destekleyecek \u015fekilde nas\u0131l y\u00f6netilebilece\u011finin daha iyi anla\u015f\u0131lmas\u0131.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Klinik ara\u015ft\u0131rmalar i\u00e7in, rejeneratif biyoloji (aksolotl laboratuvarlar\u0131), DMD klinisyenleri, memeli model sistemleri ve tedavi geli\u015ftiricileri aras\u0131ndaki i\u015f birli\u011fi hayati \u00f6nem ta\u015f\u0131yacakt\u0131r. Sonu\u00e7 olarak, aksolotl kaynakl\u0131 stratejiler DMD&#039;yi tek ba\u015f\u0131na tedavi etmese de, ya\u015fam kalitesini \u00f6nemli \u00f6l\u00e7\u00fcde iyile\u015ftirebilir, ilerlemeyi yava\u015flatabilir, kas onar\u0131m\u0131n\u0131 geli\u015ftirebilir veya gen terapileri veya ekzon atlama ile birlikte \u00e7al\u0131\u015fabilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Devam\u0131n\u0131 oku<\/strong>:&nbsp;<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne \u0130\u00e7in Klinik Ara\u015ft\u0131rmalar (T\u00fcm Ara\u015ft\u0131rmalar\u0131n Listesi)<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"watch-it-salamander-limb-regeneration\">\u0130zleyin: Semender Uzuv Yenilenmesi<\/h2>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-4-3 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<div class=\"youtube-embed\" data-video_id=\"byLDgtSMI0w\"><iframe loading=\"lazy\" title=\"Semender Uzuv Yenilenmesi \u2014 HHMI BioInteractive Video\" width=\"696\" height=\"522\" src=\"https:\/\/www.youtube.com\/embed\/byLDgtSMI0w?feature=oembed&#038;enablejsapi=1\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/div>\n<\/div><\/figure>","protected":false},"excerpt":{"rendered":"<p>Duchenne muscular dystrophy (DMD) is a severe X\u2011linked genetic disorder characterized by absence or dysfunction of dystrophin, a cytoskeletal protein essential for maintaining muscle fibre integrity. The disease leads to repeated muscle damage, inadequate repair, progressive fibrosis, loss of muscle mass and function, and eventually cardiopulmonary failure. Current therapies (gene therapy, exon skipping, corticosteroids, etc.) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4707,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[282],"tags":[427,426],"class_list":["post-4667","post","type-post","status-publish","format-standard","has-post-thumbnail","category-editorials","tag-ambystoma-mexicanum","tag-axolotl"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=4667"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4667\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/4707"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=4667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=4667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=4667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}